convalescent plasma

To date, more than 60 VA medical centers have been involved in trials on COVID-19 therapeutics (see sidebar), including antiviral drugs such as remdesivir, monoclonal antibodies, convalescent plasma, and immunomodulators. Other therapeutics are in the pipeline for clinical trials, but only one has received FDA approval.

His COVID-19 symptoms are relatively light. But he sometimes experiences debilitating nausea at random.

Some 700 Veterans who are hospitalized at VA medical centers are being enrolled in the trial, with half getting convalescent plasma and the other half in a control group.

VA is a leader in medical research that helps Veterans and all Americans. We're also part of the national research effort to find treatments for COVID-19.

Dr. Parisa Khan is a clinical pharmacist who specializes in infectious diseases at the VA Southern Nevada Healthcare System. As a recovered COVID-19 patient, she’s a candidate to help others who are experiencing symptoms from the disease.

Eastern Oklahoma VA is participating in experimental convalescent plasma therapy study. It’s hoped convalescent plasma will help people with severe COVID-19 boost their ability to fight the virus.